Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 2186-2190, April 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Too, C. K. L.
Right arrow Articles by Guernsey, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Too, C. K. L.
Right arrow Articles by Guernsey, D. L.

Increased Messenger RNA Levels of the Antagonist Thyroid Hormone Receptor erbA-{alpha}2 and Decreased Levels of erbA-{alpha}1 and erbA-ß1 Receptor Messenger RNAs in Neoplastic Rodent Cells1

Catherine K. L. Too and Duane L. Guernsey

Department sof Pathology [C. K. L. T., D. L. G.] and Physiology & Biophysics [D. L. G.], Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7

Northern blot analysis of total RNA from the mouse C3H/10T1/2 cell line indicated that the erbA{alpha} gene transcribed three mRNA species of similar sizes (2.6, 5.5, 6.6 kilobases) as found in rodents. The 2.6-kilobase mRNA (erbA-{alpha}2) was approximately 7- to 8-fold more abundant than either the 5.5- (erbA-{alpha}1) or 6.6-kilobase species. The expression of the erbA-{alpha}2 transcript increased 3- to 30-fold when "normal" mouse or rat cells were growth arrested by confluence. Triiodothyronine, at a concentration of 1 nM, had no effect on the levels of the erbA-{alpha} mRNA species in confluent cells nor on the levels of erbA-{alpha}2 in proliferative normal or transformed C3H/10T1/2 cells. In log-phase growing cells there was a 2.5- to 5-fold increase in the relative expression of erbA-{alpha}2 mRNA in transformed mouse C3H/10T1/2 cells, transformed cloned rat embryo fibroblasts (CREF), transformed rat embryo fibroblasts (REF), and a transformed temperature-sensitive rat mutant cell line (ts7E) when compared with their non-transformed counterparts. In contrast to the elevation of erbA-{alpha}2 in transformed cells, erbA-{alpha}1 and erbA-ß1 mRNAs decreased in transformed mouse and rat cell lines. In conclusion, it is suggested that the increased levels of the erbA-{alpha}2 transcript and the decreased levels of erbA-{alpha}1 and erbA-ß1 in neoplastic cells may account for the loss of thyroid hormone regulation of inducible pathways and decreased nuclear triiodothyronine binding as previously reported.

1 This work was supported by the National Cancer Institute of Canada (Grant 1618), the Dalhousie Medical Research Foundation, and the Dalhousie University Faculty of Medicine.

Received 9/30/91. Accepted 2/10/92.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.